Synthetic peptide corresponding to a region within N terminal amino acids 22-52 of Human SFT2C, conjugated to KLH.
HepG2 cell line lysate; Human hepatocarcinoma tissue
Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Immunogen affinity purified
This antibody is purified through a protein A column, followed by peptide affinity purification.
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/100 - 1/500. Predicted molecular weight: 22 kDa.
1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
SFT2C may be involved in fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complex.
Membrane; Multi-pass membrane protein
SFT2 domain containing 3 antibody
SFT2 domain-containing protein 3 antibody
Western blot - Anti-SFT2C antibody (ab104057)
Anti-SFT2C antibody (ab104057) at 1/100 dilution + HepG2 cell line lysate at 35 µg
Predicted band size: 22 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SFT2C antibody (ab104057)
ab104057, at a 1/50 dilution, staining formalin fixed and paraffin embedded Human hepatocarcinoma tissue by Immunohistochemistry. Developed using peroxidase conjugated secondary antibody and DAB staining.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"